InnoMedica Holding AG
|Category:||Clinical Stage Biotech Company|
|Time:||13:00 – 13:15|
|Speaker:||Dr. Jonas Zeller, CFO|
InnoMedica’s vision is to replace the systemic application of drugs with a targeted, and therefore gentler, approach by refining the most effective active ingredients into intelligent therapies using liposomal nanotechnology. The mission is therefore to enhance therapies for diseases with great therapeutic need, such as cancer, Parkinson’s or ALS, or to make therapy possible in the first place, in order to achieve real medical progress for the people affected.